Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda

Positive

AI Analysis

Summary

IQVIA Institute reports global cancer medicine spending reached $252 billion in 2024 and forecasts it will exceed $400 billion by 2028, with the US representing approximately 46% of total spending.

Financial Highlights

Revenue

$252 billion (2024), forecast >$400 billion (2028)

Importance:2/10

Sentiment:

0.30

market analysiscancer drugsspending forecastcolorectal cancerpancreatic cancer

Related Companies

$IQV

Read the original article

Published by PR Newswire Biotech on October 14, 2026 8:07 AM

Read Original